Abstract
The advent of new antiretroviral agents has dramatically reduced mortality and HIVassociated morbidity. In the highly active antiretroviral therapy (HAART) era, longterm side effects have been reported such as severe metabolic disorders and related acute cardiovascular complications including myocardial infarction, peripheral vascular disease, and stroke. Prevention and therapeutics for cardiovascular complications in HIV-infected patients are a new and emerging challenge for physicians involved in HIV infection care because of the prolongation of survival and long-term complications of HAART. In the present overview, we discuss the clinical presentation, pathophysiology, prognosis, prevention, and treatment of coronary heart disease (CHD) in HIV-infected patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
